| |
| |
|
| Insider
Information: |
Tzianabos Arthur |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
200,917 |
|
|
Indirect Shares
|
1,000 |
|
|
| Direct
Value |
$2,423,483 |
|
|
|
Indirect Value
|
$1,060 |
|
|
| Total
Shares |
201,917 |
|
|
| Total
Value |
$2,424,543 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tempest Therapeutics, Inc |
TPST |
President and CSO |
2015-12-03 |
25,400 |
2015-12-03 |
1,000 |
Premium* |
|
|
DNIB Upwind Inc |
BIND |
Director |
2016-08-26 |
15,000 |
2016-08-26 |
0 |
Premium* |
|
|
Q32 Bio Inc |
QTTB |
|
2024-01-09 |
128,778 |
2019-06-03 |
0 |
Premium* |
|
|
Akouos, Inc. |
AKUS |
Director |
2022-11-30 |
0 |
|
0 |
Premium* |
|
|
Stoke Therapeutics, Inc. |
STOK |
|
2024-02-13 |
31,739 |
2020-11-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
27 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
27 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
